CCTN - MALE CONTRACEPTIVE TRIAL DMAU-SEDDS STUDY
$527,985N01FY2016HDNIH
University Of Washington, Seattle WA
Investigators
Abstract
Phase I Male Contraceptive Trial, Dimethylandrolone undecanoatehase (DMAU), shown in animal studies to inhibit spermatogenesis. Test single dose in man. Male Contraceptive Trial DMAU with Self-Emulsifying Drug Delivery System (SEDDS) Study
View original record on NIH RePORTER →